Skip to main content
VCbacked
Log inGet Started

Protego Biopharma

San Diego, United States

Protego Biopharma is a biotechnology company that develops therapeutics that aim to correct diseases caused by protein misfolding.

$130.0M raised
Dec 2025
Series B
BiopharmaBiotechnologyMedicalTherapeutics

Top Investors

Lightspeed Venture PartnersDigitalis VenturesOmega FundsForbion Capital PartnersVida Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Protego Biopharma

How much funding has Protego Biopharma raised?
Protego Biopharma has raised $130.0M in total funding. The most recent round was Series B. The last funding was announced in December 2025.
Who are Protego Biopharma's investors?
Protego Biopharma's investors include Lightspeed Venture Partners, Digitalis Ventures, Omega Funds, Forbion Capital Partners, Vida Ventures.
Where is Protego Biopharma headquartered?
Protego Biopharma is headquartered in San Diego, United States.
What does Protego Biopharma do?
Protego Biopharma is a biotechnology company that develops therapeutics that aim to correct diseases caused by protein misfolding.
What stage is Protego Biopharma at?
Protego Biopharma is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Protego Biopharma — Funding & Investors." VCBacked, December 1, 2025, https://www.vcbacked.co/company/protego-biopharma. Accessed June 17, 2026.
APA
VCBacked. (2025). Protego Biopharma — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/protego-biopharma
Wikipedia (cite web)
{{cite web |title=Protego Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/protego-biopharma |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
Ember LifeSciences
Los Angeles$16.5M
ClearNote Health
San Diego